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SUMMARY – Breast cancer is the most frequently diagnosed cancer and the leading cause of 
death from cancer in women. Th e accuracy of diagnosis can be increased with a combination of clini-
cal examination, imaging diagnostics, and fi ne needle aspiration cytology (FNAC) or core needle bi-
opsy, also known as triple test. Th e aim of the study was to evaluate the sensitivity and specifi city of 
FNAC in the diagnosis of breast tumors in our institution by correlating it with histopathology fi nd-
ings. We assessed the accuracy of 124 FNAC fi ndings by comparing cytological diagnosis of breast 
masses with the diagnoses from histopathology reports obtained by surgery. Statistical analysis showed 
95.1% accuracy, 97.7% sensitivity, 89.1% specifi city, 95.5% positive predictive value and 94.2% 
negative predictive value of FNAC. Study results indicated that FNAC could be used as a high-
ly reliable tool in the diff erential diagnosis of breast tumors, in combination with clinical and imaging 
fi ndings, especially in developing countries with limited fi nancial resources.
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Introduction
Breast cancer is the most frequently diagnosed 
cancer and the leading cause of death from cancer in 
women. Breast cancer survival rates tend to be poorer 
in developing countries, most likely because of a com-
bination of late diagnosis and limited access to timely 
and appropriate treatment1. Th e accuracy of diagnosis 
can be increased with a combination of clinical exami-
nation, imaging diagnostics, and fi ne needle aspiration 
cytology (FNAC) or core needle biopsy, also known as 
triple test2. FNAC is a minimally invasive, simple, 
cost-eff ective, safe and sensitive method for breast tu-
mor diagnosis3. Many authors have shown that FNAC 
is highly accurate in the diagnosis of breast tumors4,5. 
Using the ultrasound guided method, FNAC has been 
used more widely for non-palpable breast tumors6,7. 
Although core biopsy is preferred to FNAC in most 
developed countries, its procedure is more expensive 
and time consuming as compared to FNAC8-10.
Th is study was conducted to evaluate the sensitivity 
and specifi city of FNAC in the diagnosis of breast tu-
mors in our institution by correlating it with histopa-
thology fi ndings.
Materials and Methods
Th is retrospective study was conducted at the Clin-
ical Department of Pathology, Cytology and Forensic 
Medicine, Mostar University Hospital in Mostar, Bos-
nia and Herzegovina. Data were collected from the 
archives of our institution for women with breast 
masses having received FNA cytological diagnosis and 
histopathologic evaluation during the period from 
January 2012 to December 2013. We assessed the ac-
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curacy of FNA fi ndings by comparing cytological di-
agnoses of breast masses to the diagnoses from histo-
pathology reports obtained by surgery. FNA was ob-
tained through a 22-24-gauge needle; the aspirated 
content was then smeared on a glass slide, air-dried 
and stained with May-Grünwald-Giemsa for 30 min. 
Cytological diagnoses were classifi ed into 3 categories: 
benign, suspect and malignant. Benign category in-
cludes poor cellularity, good cohesion and fl at sheets of 
cells, and smooth or fi ne chromatin with no nuclear 
irregularity. Malignant category includes high cellular-
ity, poor cohesion and three-dimensional arrangement 
of cells, clumped chromatin with variable nuclear size 
and pleomorphism. Suspect category should be used 
when the cytologist is almost certain that they come 
from a malignant lesion, although a confi dent diagno-
sis cannot be made.
Statistical analysis to determine sensitivity, speci-
fi city, positive predictive value and negative predictive 
value with their 95% confi dence intervals was per-
formed using the SPSS 13.0 for Windows statistical 
software (SPSS Inc., Chicago, Illinois, USA). All val-
ues were calculated for the benign and malignant 
groups only, and for the benign, malignant and suspect 
groups together. Th e suspect and malignant cases were 
grouped together, based on the assumption for suspect 
cases to be positive for malignancy.
Th e study was approved by the Ethics Committee 
of the Mostar University Hospital and in accordance 
with the Helsinki Declaration11.
Results
In this study, we collected 124 FNA diagnoses and 
histopathology reports. Median age was 46 (range 16-
88) years. Out of 124 cases according to FNA, there 
were 35 (28.2%) benign, 83 (66.9%) malignant and 6 
(4.8%) suspect cases. Out of the 85 confi rmed malig-
nant cases, 80 cases were malignant on cytology, 
5 cases were suspect of malignancy, and 2 cases were 
benign. Th ere were 3 benign cases confi rmed by histol-
ogy which were classifi ed as malignant by cytology 
report (Table 1). Th e most common causes of false-
positive cytological diagnosis were atypical lobular 
 hyperplasia, papilloma and spreading artifacts. Th e 
most common cause of false-negative cytological diag-
nosis was inadequate aspiration. Table 2 summarizes 
data on the overall accuracy, sensitivity, specifi city, pos-
itive predictive value and negative predictive value of 
FNA.
Discussion
Accurate diagnosis of breast tumors can help avoid 
unnecessary surgical procedures and plan correct treat-
ment options. Every patient with breast tumor should 
undergo triple test to make early and accurate diagno-
sis. FNA is widely used in the diff erential diagnosis of 
breast tumors because of the high level of accuracy, 
rapid results, and for being a less invasive procedure 
than tissue biopsy12,13. Th e accuracy, sensitivity and 
specifi city found in our study showed FNA of breast 
tumors to be a reliable method for diff erential diagno-
sis of benign from malignant masses. Our study fi nd-
ings are consistent with those reported in the litera-
ture1,4,14. We had 4.8% of suspect FNA diagnoses. 
Th ese fi ndings are in line with previous reports15. Ac-
cording to various studies, the false-positive rate rang-
es from 0 to 2.5%, which is slightly lower than 3.2% 
found in this study4,5,15. Th e false-negative rate in our 
study was 1.6%, which is lower in comparison to other 
Table 1. Comparison of fi ne needle aspiration cytology 








Benign 33 (97.1) (TN) 2 (2.9) (FN) 35 (100)
Suspect 1 (33.3) (FP) 5 (66.7) (TP) 6 (100)
Malignant 3 (4.8) (FP) 80 (95.2) (TP) 83 (100)
Total 39 (100) 85 (100) 124 (100)
FN = false negative; FP = false positive; TN = true negative; 
TP = true positive
Table 2. Diagnostic values of fi ne needle aspiration 







Specifi city 91.6 89.1
Positive predictive value 96.3 95.5
Negative predictive value 94.2 94.2
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studies4. False-negative and false-positive results occur 
due to physician experience16,17, sample quality18 and 
certain histopathology diagnoses19. Using ultrasound 
guided FNAC increases specifi city and sensitivity of 
FNA20,21. False-positive and false-negative results can 
mislead clinicians and therefore FNA should not be 
used as the only diagnostic tool in diff erential diagno-
sis of breast tumors. Results of FNAC should be inter-
preted in correlation to clinical and imaging fi ndings, 
thus reducing the risk of missed diagnosis of breast 
cancer22-24. Even though diagnostic accuracy of core 
needle biopsy and FNA is similar24, many physicians 
prefer core needle biopsy as a technique superior to 
FNA because core needle biopsy can better detect 
ductal carcinoma in situ and off ers better histopatho-
logic and immunohistochemical evaluation of tumor 
tissues25,26. Evaluation of estrogen receptor can also be 
done in cytologic material, which is favorable for some 
patients, particularly those undergoing preoperative 
chemotherapy or irradiation, or those with inoperable 
primary tumor27-29. Because FNA is less traumatic and 
easier technique than core needle biopsy, it can be re-
peated in the same day in case of unsatisfactory sam-
ples. FNA is cost-eff ective even when followed by core 
needle biopsy or surgical excision8. Th erefore, it is pos-
sible to introduce FNA procedure into smaller hospi-
tals where physicians are less experienced with this 
technique30,31. Th is study indicated that FNA could be 
used as a highly reliable tool, in combination with clin-
ical and imaging fi ndings, in the diff erential diagnosis 
of breast tumors, especially in developing countries 
with limited fi nancial resources.
Conclusion
Th is study indicated FNA to be an accurate and 
highly reliable tool in the assessment of breast tumors. 
With high sensitivity and specifi city, most breast tu-
mors can be reliably diagnosed by FNA. It is a simple, 
safe, cost-eff ective and accurate method for the initial 
diagnosis and for guiding treatment. However, one 
must be aware of the possibility of false-positive and 
false-negative results. All patients with breast tumors 
should be diagnosed based on a combination of physi-
cal examination, radiological diagnostics and FNA. 
FNA is an acceptable and reliable procedure for the 
preoperative diagnosis of breast tumors, particularly in 
developing countries.
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Sažetak
DIJAGNOSTIČKA VRIJEDNOST CITOLOŠKE PUNKCIJE TANKOM IGLOM KOD TUMORA DOJKE
J. Mišković, A. Zorić, H. Radić Mišković i V. Šoljić
Karcinom dojke je najčešći zloćudni tumor i vodeći uzrok smrti od zloćudne bolesti kod žena. Pravodobnost i točnost 
dijagnoze mogu se poboljšati kombinacijom kliničkog pregleda, radioloških pretraga i citološke punkcije tankom iglom ili 
core biopsije. Istraživanje je provedeno kako bi se utvrdila osjetljivost i specifi čnost citološke punkcije tankom iglom tumora 
dojke u odnosu na patohistološki nalaz. U istraživanje je uključeno 124 nalaza citološke punkcije tankom iglom tumora 
dojke koji su uspoređeni s patohistološkim nalazom nakon kirurške resekcije. Statistička analiza je pokazala točnost od 
95,1%, osjetljivost od 97,7%, specifi čnost od 89,1%, pozitivnu prediktivnu vrijednost od 95,5% i negativnu prediktivnu 
 vrijednost od 94,2%. Istraživanje je pokazalo da se citološka punkcija tankom iglom može koristiti kao veoma pouzdana 
pretraga u diferencijalnoj dijagnozi tumora dojke, u kombinaciji s kliničkim pregledom i radiološkim pretragama, pogotovo 
u zemljama u razvoju s ograničenim materijalnim sredstvima.
Ključne riječi: Citološka punkcija tankom iglom; Dojka; Tumori; Patohistologija
